Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DR26FBQDK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,212
Award facts
- Contract value 100% obligated
- $26,211.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on June 22, 2026, with a ceiling value of $26,211.60, for Xolair 300 mg/2 ml autoinjector supply under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).
DMS Pharmaceutical is a woman-owned small business. Place of performance is Park Ridge, Illinois. The ultimate completion date is July 14, 2026. The order is priced on a firm fixed-price basis with no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26FBQDK?
SPE2DR26FBQDK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 22, 2026.
How much is contract SPE2DR26FBQDK worth?
The government has obligated $26,212 on SPE2DR26FBQDK.
Is contract SPE2DR26FBQDK an order under another contract?
Yes. SPE2DR26FBQDK is a delivery order under SPE2DR25D9304, an indefinite delivery contract.
Was contract SPE2DR26FBQDK competed?
The extent of competition for SPE2DR26FBQDK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award